Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5733)
All Articles published online
|
Publishing Process of This Article
|
Jun 24, 2020 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao D, Xie B, Yang Y, Yan P, Liang SN, Lin Q. Progress in immunotherapy for small cell lung cancer. World J Clin Oncol 2020; 11(6): 370-377 [PMID: 32874950 DOI: 10.5306/wjco.v11.i6.370] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i6/370.htm |
| Number | Citing Articles |
| 1 |
Qian Chen, Kai Zheng, Ming Xu, Ning Yan, Gong Hai, Xiuchun Yu. Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1283932
|
| 2 |
Zhi-Yuan Chen, Hui-Wen Xiao, Jia-Li Dong, Yuan Li, Bin Wang, Sai-Jun Fan, Ming Cui. Gut Microbiota-Derived PGF2α Fights against Radiation-Induced Lung Toxicity through the MAPK/NF-κB Pathway. Antioxidants 2021; 11(1): 65 doi: 10.3390/antiox11010065
|
| 3 |
Bing Lv, Jing Chen, Xiao-Liang Liu. Anlotinib-Induced Hypertension: Current Concepts and Future Prospects. Current Pharmaceutical Design 2022; 28(3): 216 doi: 10.2174/1381612827666211006145141
|
| 4 |
Hsiao-Ling Chen, Yu-Kang Tu, Hsiu-Mei Chang, Tai-Huang Lee, Kuan-Li Wu, Yu-Chen Tsai, Mei-Hsuan Lee, Chih-Jen Yang, Jen-Yu Hung, Inn-Wen Chong. Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma. Cancers 2020; 12(12): 3629 doi: 10.3390/cancers12123629
|
| 5 |
Anand Rotte, Srikumar Sahasranaman, Nageshwar Budha. Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development. Biomedicines 2021; 9(9): 1277 doi: 10.3390/biomedicines9091277
|